Webcast - Lung Cancer Screening Updates 2022"
Activity Evaluation
Please complete the evaluation and posttest to obtain CME credit.
*
1.
First and Last Name, credentials (M.D., D.O., R.N. etc.)
(Required.)
*
2.
Attestation
I attest that I have completed the participant requirements for this CME activity.
(Required.)
Yes
No
3.
Activity objectives were met?
Understand the evidence behind and the importance of Lung Cancer Screening in the high risk patient; describe new eligibility guidelines for lung cancer screening per 0-2/2022 CMS Decision Memo; list three barriers to lung cancer screening; implement best practices for interactions with patients.
Yes
No
4.
This activity impacted or increased the following:
Medical Knowledge
Competency
Performance
5.
This activity addressed the following areas and will increase or enhance the following in my practice (check all that apply)
Patient outcomes
Communication skills (peer to peer and/or patient)
Practice-based systems (evaluation or change to professional practice)
System-based practice (overall evaluation or change to organization or system practice)
6.
Was this activity free from bias?
Yes
No
7.
Was this activity evidenced-based?
Yes
No
8.
What percent of lung cancer cases are diagnosed at an early stage?
12%
16%
65%
9.
Clinical outcome for non-small cell lung cancer is directly related to?
10.
What is the number one cause of lung cancer among non-smokers?
Cigarettes
Radon
Vaping